Publikācijas » 2009

Rezultātu skaits lapā  
Konferences
41Dambrova M.; Konrade I.; Jankevics A.; Skapare E.; Pugovics O.; Liepinsh E. The comparative metabolomics of the experimental rat and diabetic patients urinary composition. Abstract Volume in Journal of the European Association fot the Study of Diabetes (EASD) (Diabetologia, Vol.52, Suppl.1), 45th EASD Annual Meeting; 29 September - 2 October: Vienna, Austria, 2009; 145.      

42Dambrova M. Regulation of cellular energy metabolism by mildronate. Different pharmacological activity of optical isomers of CNS active drugs. Abstracts, The 2nd Korea International Women,s Invention Exposition-Forum; May 1-4, 2009; 159.      

43Makrecka M.; Kūka J.; Škapare E. Metabolā sindroma un otrā tipa diabēta eksperimentālo modeļu salīdzinājums. Tēzes, 58. Medicīnas nozares studentu zinātniskā konference; 1. aprīlis: Rīgas Stradiņa Universitāte, Latvija, 2009; 12.      

44Skorova A.; Veretennikova N.; Lukevics E. Prediction of biological activity for organic compounds using OREX expert system. Scientific Programme. Plenary Lecture, Major Talks, Short & Oral Communications. Abstracts a. Background of the Speakers, International Symposium on Advances in Synthetic and Medicinal Chemistry = ASMC; August 23-27: Kiev, Ukraine (www.asmc09.org), 2009; 190.      

45Skrivele B.; Pajuste K.; Kaldre D.; Plotniece A.; Ose V.; Sobolev A.; Danne R.; Cekavicus B.; Birjukovs P.; Erts D.; Duburs G. The influence of preparation conditions on nanoaggregates formed by self-assembling amphiphilic pyridinium derivatives. Abstracts, 23rd Conference of the European Colloid and Interface Society = ECIS 2009 (September 6-11), 3rd D43 Action Workshop (September 7-8); : P.D43.055. Antalya, Turkey, 2009.      

46Svalbe B.; Zvejniece L.; Muceniece R.; Dambrova M. Anti-inflammatory and antinociceptive effects of NF-kappaB inhibitor. Abstracts, 13th annual Symposium for Biology Students of Europe = SymBioSE2009. Biology: Expansion of Borders ; 30 July – 8 August: Kazan State University, Tatarstan Republic, Russia, 2009; 110.      

47Zvejniece L.; Dambrova M. Differential pharmacological activity of optical isomers of CNS drugs. Program. Book of Abstracts, 3rd International Symposium on Evidence Based Medicine on CNS, Sleep & Chronic Organic Disorders. 1st Latvian-Greek Medical Symposium; 3rd-6th July: Riga, Latvia, 2009; 38.      

48Kuka J.; Zinovjevs K.; Skapare E.; Liepinsh E. Caracterization of mildronate as an inhibitor of carnitine acetyltransferase. Abstracts (FEBS Journal 276, Suppl.1), 34th FEBS Congress. Life's Molecular Interactions (www.febsjournal.org); July 4 - 9: P8-85. Prague, Czech Republic, 2009; 322.      

49Vilskersts R.; Kuka J.; Svalbe B.; Liepinsh E.; Dambrova M. Mildronate ororate: its cardioprotective and antiarrhythmic effects and mechanism of action. Abstracts (FEBS Journal 276, Suppl.1), 34th FEBS Congress. Life's Molecular Interactions (www.febsjournal.org); July 4 - 9: P8-181. Prague, Czech Republic, 2009; 351.      

50Skapare E.; Vilskersts R.; Svalbe B.; Dambrova M. The beneficial effects of inhibitor of L-carnitine biosynthesis in experimental rat model of type 2 diabetes. Abstracts (FEBS Journal 276, Suppl.1), 34th FEBS Congress. Life's Molecular Interactions (www.febsjournal.org); July 4 - 9: P8-158. Prague, Czech Republic, 2009; 334.      

Rezultātu skaits lapā